1. Introduction {#sec1}
===============

Systemic Capillary Leak Syndrome (SCLS) is a rare disease with severe prognosis. Capillary endothelium hyperpermeability causes extravascular leakage of plasma into the interstitial area, explaining the double symptoms of this disease: mucocutaneous and visceral edema, as well as hypovolemic shock with hemoconcentration with paradoxical hypoalbuminemia. The disease can be idiopathic (Clarkson syndrome) or secondary to other diseases and treatments \[[@B1]\]. Initially, the main risk is acute pulmonary edema and compartment syndrome, aggravated by massive vascular filling \[[@B1]\]. This study describes the syndrome in a prehospitalized patient.

2. Case Presentation {#sec2}
====================

A 63-year-old man presented with two days\' digestive symptoms: nausea, vomiting, diarrhea, and abdominal pain with fever and asthenia. The patient had a history of hypertension (treated with amlodipine), chronic lymphocytic leukemia stage A with a monoclonal gamma peak, and septic shock in 2012. Six month earlier, a routine blood sample analysis showed no abnormality with the notable exception of a peak of gammaglobulins (16,4 g/L). At his home, the paramedical team found high blood pressure and oxygen saturation and a heart rate of 102 per minute in a pale patient, sweating and asthenic, and no neurological disorder. He had abdominal pain without tenderness, nausea, and hypothermia at 33.8°C. He showed no chest pain, no signs of heart failure, and no radial pulse, and his veins of the lower limbs and abdomen were apparent. He had a pulmonary surface polypnea at 34 per minute and cyanosis of the extremities (SpO~2~ 84%), but normal auscultation. HemoCue was at 23.6 g/dL and glucose was at 1.7 g/L. Proteinuria was negative on a urinal quick test, the protein was 43 g/L, and glomerular renal filtration was found at 30 mL/min. Albumin was at 24.7 g/L and all blood immunoglobulins were low. Concerning liver laboratory findings, only gamma GT was 3 times higher than normal. The electrocardiogram revealed a sinus rhythm at 100 per minute with a narrow QRS without conduction disturbance or repolarization.

After 750 mL of vascular filling and a continuous unstable hemodynamic status, norepinephrine was introduced. Orotracheal intubation through ventilatory depletion after rapid sequence induction was then carried out.

A thoracoabdominal pelvic CT scan did not find any abnormality or visceral edema. Biological results revealed hyperhemoglobin at 23 g/dL albumin associated with paradoxical hypoalbuminemia at 20 g/L. Hematological results then evoked a diagnosis of SCLS. Intravenous immunoglobulin therapy CLAIRYG® was established.

Within hours, the clinical condition deteriorated hemodynamically requiring new massive filling and an increase of catecholamine doses. In this hypoxemic and vasoplegic context with multiple organ failure and persistent acidosis, the patient presented with refractory cardiac arrest and died minutes later. All bacteriological samples were sterile.

3. Discussion {#sec3}
=============

Systemic Capillary Leak Syndrome was first described in 1960 \[[@B2]\]. Analysis of cases published since shows that the average age of onset of symptoms is about 45 years without sex predominance (M/F = 1.2) \[[@B1], [@B3]\]. Subjects are mostly Caucasians \[[@B4]\], and rare pediatric forms have been reported \[[@B1], [@B4]--[@B6]\]. Secondary forms are primarily associated with hematological malignancies, viral infections in particular, and certain medications including blood cancer \[[@B1]\]. Diagnosis of idiopathic SCLS is evoked without predisposing circumstances, particularly since there is a monoclonal immunoglobulin in the majority of cases \[[@B1]\] with a recurrent seizure characteristic. Concerning this case, a nephrotic syndrome was evoked but not compatible with the negative proteinuria, and we excluded a transition into some different hematologic malignoma, considering the normality of the liver laboratory findings.

The typical clinical presentation consists of three phases: the prodromal phase until the 48th hour with weight gain, fatigue, faintness, low-grade fever, and head and neck or gastrointestinal symptoms related to mucosal edema. The status phase includes weight gain, oedema in the lungs, oliguria, hypotension up to and including shock, and preserved consciousness. The pressure invasive monitoring and cardiovascular rates confirm the diagnosis of hypovolemic shock \[[@B7]--[@B9]\]. During recovery beginning between the 5th and 7th day, the patient feels a sense of "feeling better" with normalization of blood pressure, polyuria, disappearance of oedema, and weight loss \[[@B1]\].

Laboratory abnormalities most often encountered are those presented by this patient with hemoconcentration, hyposerum protein and hypoalbumin, decreased TP leakage factor 5, acute renal failure, and rhabdomyolysis \[[@B1], [@B4], [@B10]\]. Complications are caused by the transfer of the vascular sector into the interstitial area with acute pulmonary edema and rhabdomyolysis, particularly since, in this case, vascular filling would have been massive and rapid \[[@B1]\].

The therapeutic management is common to idiopathic or secondary SCLS. The patient should be transferred to intensive care and fluid resuscitation must be given with caution with isotonic NaCl and guided by diuresis. Vasoactive amines are recommended in case of early signs of hypoperfusion, if possible with norepinephrine because it is less arrhythmogenic and if necessary extrarenal purging in case of acute renal failure \[[@B1], [@B10], [@B11]\].

In cases of idiopathic SCLS, long-term treatments have been proposed by some authors, but without formally being proven effective. They target antihistamines and beta 2 agonists with terbutaline and theophylline \[[@B1], [@B4], [@B10]--[@B13]\]. More recently in a European register, analysis of patients treated with immunoglobulin intravenously at a dose of 2 g/kg per month showed a decrease in the frequency of occurrence and severity of seizures in treated patients. Curative proof is still low at this time \[[@B10], [@B14]\].
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